Literature DB >> 24356768

Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Tomohide Yoneyama1, Yoshihiko Fukukura, Kiyohisa Kamimura, Koji Takumi, Aya Umanodan, Shinichi Ueno, Masayuki Nakajo.   

Abstract

OBJECTIVE: We aimed to develop and assess the efficacy of a liver function index that combines liver enhancement and liver volume to standard liver volume (LV/SLV) ratio on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.
METHODS: In all, 111 patients underwent a Gd-EOB-DTPA-enhanced MRI, including T1 mapping, before and 20 min after Gd-EOB-DTPA administration. We calculated the following Gd-EOB-DTPA-enhanced MRI-based liver function indices: relative enhancement of the liver, corrected enhancement of the liver-to-spleen ratio, LSC_N20, increase rate of the liver-to-muscle ratio, reduction rate of T1 relaxation time of the liver, ΔR1 of the liver and K Hep; the indices were multiplied by the LV/SLV ratio. We calculated the correlations between an indocyanine green (ICG) clearance and the Gd-EOB-DTPA-enhanced MRI-based liver function indices multiplied by the LV/SLV ratio, by using Pearson correlation analysis.
RESULTS: There were significant correlations between all Gd-EOB-DTPA-enhanced MRI-based liver function indices and ICG clearance (r = -0.354 to -0.574, P < 0.001). All Gd-EOB-DTPA-enhanced MRI-based liver function indices multiplied by the LV/SLV ratio (r = -0.394 to -0.700, P < 0.001) were more strongly correlated with the ICG clearance than those without multiplication by the LV/SLV ratio.
CONCLUSIONS: Gd-EOB-DTPA-enhanced MRI-based liver function indices that combine liver enhancement and the LV/SLV ratio may more reliably estimate liver function. KEY POINTS: • Gd-EOB-DTPA-enhanced MRI is useful for assessing liver function. • Liver enhancement on Gd-EOB-DTPA-enhanced MRI correlates with indocyanine green (ICG) clearance. • Liver volume to standard liver volume (LV/SLV) ratio correlates with ICG clearance. • Liver enhancement and LV/SLV ratio help to estimate liver function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356768     DOI: 10.1007/s00330-013-3086-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  43 in total

1.  Is liver fibrosis reversible?

Authors:  P A Bonis; S L Friedman; M M Kaplan
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

2.  High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI).

Authors:  Sean C L Deoni
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

3.  The indocyanine green test enables prediction of postoperative complications after hepatic resection.

Authors:  T Matsumata; T Kanematsu; Y Yoshida; T Furuta; K Yanaga; K Sugimachi
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

4.  Assessment of liver volume variation to evaluate liver function.

Authors:  Cong Tong; Xinsen Xu; Chang Liu; Tianzheng Zhang; Kai Qu
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

5.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

6.  Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation.

Authors:  Kyung Ah Kim; Mi-Suk Park; In-Seong Kim; Berthold Kiefer; Woo-Suk Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  J Magn Reson Imaging       Date:  2012-03-05       Impact factor: 4.813

7.  Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.

Authors:  Tsutomu Tamada; Katsuyoshi Ito; Atsushi Higaki; Koji Yoshida; Akihiko Kanki; Tomohiro Sato; Hiroki Higashi; Teruki Sone
Journal:  Eur J Radiol       Date:  2011-02-18       Impact factor: 3.528

8.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

9.  Estimation of standard liver volume for Japanese adults.

Authors:  T Yoshizumi; A Taketomi; H Kayashima; Y Yonemura; N Harada; H Ijichi; Y Soejima; T Nishizaki; Y Maehara
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

10.  Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA.

Authors:  Bengt Norén; Mikael Fredrik Forsgren; Olof Dahlqvist Leinhard; Nils Dahlström; Johan Kihlberg; Thobias Romu; Stergios Kechagias; Sven Almer; Örjan Smedby; Peter Lundberg
Journal:  Eur Radiol       Date:  2012-07-27       Impact factor: 5.315

View more
  30 in total

1.  Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging.

Authors:  Nobuhiro Fujita; Akihiro Nishie; Yuichiro Kubo; Yoshiki Asayama; Yasuhiro Ushijima; Yukihisa Takayama; Koichiro Moirta; Ken Shirabe; Shinichi Aishima; Hiroshi Honda
Journal:  Eur Radiol       Date:  2014-07-26       Impact factor: 5.315

2.  Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Munyoung Paek; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

3.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test.

Authors:  Michael Haimerl; Irene Fuhrmann; Stefanie Poelsterl; Claudia Fellner; Marcel D Nickel; Kilian Weigand; Marc H Dahlke; Niklas Verloh; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

4.  Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Josiah Simeth; Adam Johansson; Dawn Owen; Kyle Cuneo; Michelle Mierzwa; Mary Feng; Theodore S Lawrence; Yue Cao
Journal:  NMR Biomed       Date:  2018-04-19       Impact factor: 4.044

5.  Imaging-based evaluation of liver function: comparison of ⁹⁹mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Vera Fröling; Maciej Malinowski; Martin Stockmann; Annekathrin Baron; Bernhard Gebauer; Daniel Seehofer; Vikas Prasad; Timm Denecke
Journal:  Eur Radiol       Date:  2014-12-02       Impact factor: 5.315

6.  Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.

Authors:  Claudia Khouri Chalouhi; Federica Vernuccio; Francesca Rini; Piergiorgio Duca; Bruno Tuscano; Giuseppe Brancatelli; Angelo Vanzulli
Journal:  Eur Radiol       Date:  2018-12-13       Impact factor: 5.315

7.  Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.

Authors:  Michael Haimerl; Mona Schlabeck; Niklas Verloh; Florian Zeman; Claudia Fellner; Dominik Nickel; Ana Paula Barreiros; Martin Loss; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2015-07-18       Impact factor: 5.315

8.  T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method.

Authors:  Ji Eun Kim; Hyun Ok Kim; Kyungsoo Bae; Dae Seob Choi; Dominik Nickel
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

9.  Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC).

Authors:  Heiko Hinrichs; Jan B Hinrichs; Marcel Gutberlet; Henrike Lenzen; Hans-Juergen Raatschen; Frank Wacker; Kristina I Ringe
Journal:  Eur Radiol       Date:  2015-07-24       Impact factor: 5.315

10.  Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.

Authors:  Simon Matoori; Johannes M Froehlich; Stefan Breitenstein; Aleksis Doert; Viktoria Pozdniakova; Dow-Mu Koh; Andreas Gutzeit
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.